2022 annual financial data
C4 Therapeutics, Inc. 2022 Operating margin
C4 Therapeutics, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was -416.56%.
Operating income was -129,534,000 USD and net income was -128,175,000 USD.
Operating cash flow was -105,939,000 USD.
Get free C4 Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,096,000 USD
- Operating income
- -129,534,000 USD
- Net income
- -128,175,000 USD
- Operating cash flow
- -105,939,000 USD